A Multi-atlas Approach for Active Bone Marrow Sparing Radiation Therapy: Implementation in the NRG-GY006 Trial

Keyphrases

• Radiation Therapy 100%
• Active Marrow 100%
• Multi-atlas 100%
• Bone Marrow Sparing 100%
• Atlas-based 41%
• 95% Confidence Interval 25%
• Dice Similarity Coefficient 16%
• Pelvic Bone Marrow 16%
• Positron Emission Tomography/computed Tomography (PET/CT) 16%
• Dose-volume Metrics 16%
• No Significant Difference 8%
• Prospective Clinical Trial 8%
• Training Set 8%
• Clinical Trials 8%
• Segmentation Method 8%
• Linear Regression 8%
• Dosimetry 8%
• Bladder 8%
• CT Images 8%
• Cervical Cancer 8%
• Rectum 8%
• Bowel 8%
• Standardized Uptake Value 8%
• Pelvic Bones 8%
• Normal Tissue Complication Probability 8%
• Intensity-modulated Radiation Therapy 8%
• Femoral Head 8%
• Segmentation-based 8%
• Mean Standard Deviation 8%
• Chemoradiotherapy 8%
• Mean Distance 8%
• Target Dose 8%
• Acute Hematologic Toxicity 8%
• 18F-fluorodeoxyglucose Positron Emission Tomography/computed Tomography (18F-FDG PET/CT) 8%
• Subvolume 8%

Medicine and Dentistry

• Positron Emission Tomography-Computed Tomography 100%
• Radiation Therapy 100%
• pelvic bones 100%
• Clinical Trial 66%
• Dosimetry 33%
• Linear Regression Analysis 33%
• Chemoradiotherapy 33%
• Bladder 33%
• Fluorodeoxyglucose F 18 33%
• Standardized Uptake Value 33%
• Intensity Modulated Radiation Therapy 33%
• Cervical Cancer 33%
• Femoral Head 33%